News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Deja Vu: Second Probe Finds Manipulated Trial Data for Novartis AG (NVS) Drug


7/31/2013 7:41:29 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The scandal over research into the Diovan heart drug in Japan is beginning to resemble a game of Whack-A-Mole. One day after Novartis attempted to put the matter to rest by announcing its own investigation was completed, another university has disclosed that data in a trial was manipulated and the first author of the study, a professor at the university, says the work will be retracted. In a press conference, Kazuhiro Hashimoto, who chairs an investigation committee at the Jikei University School of Medicine, indicated that a former Novartis employee might have manipulated the data, while noting that the former worker denied wrongdoing in an interview, according to The Japan Times.

Help employers find you! Check out all the jobs and post your resume.

Read at Pharmalot
Read at Japan Times
Read at Forbes
Read at The Standard
Read at PharmaLive


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES